Showing posts with label Lorcaserin. Show all posts
Showing posts with label Lorcaserin. Show all posts
Friday, March 27, 2020

FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk

›
In continuation of my update on  lorcaserin The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the r...
Saturday, June 24, 2017

Study provides insight into how weight-loss drug acts in the brain

›
In  continuation  of  my update on  lorcaserin A weight-loss drug dampened the response to food cues in regions of the brain associa...
Monday, May 1, 2017

Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of Belviq XR (lorcaserin HCl) Extended-Release Tablets

›
In continuation of my update on Lorcaserin Eisai Inc. and Arena Pharmaceuticals, Inc.   announced   the approval by  U.S. Food and Drug ...
Tuesday, September 11, 2012

Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese (NASDAQ:ARNA)

›
In continuation of my update on lorcaserin Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chroni...
Tuesday, June 5, 2012

Lorcaserin Receives Positive Vote From FDA Advisory Committee

›
In continuation of my update on Lorcaserin Lorcaserin Receives Positive Vote From FDA Advisory Committee :   (FDA) Endocrinologi...
Monday, November 9, 2009

Positive results from Phase 3 trial of wieght reducing drug Lorcaserin...

›
We knew that Lorcaserin, is a serotonergic weight-loss drug developed by Arena Pharmaceuticals. It is currently undergoing the final phase o...